Abirapro Abiraterone Acetate Tablets

Product Description

Prostate cancer is treated with the prescription drug Abirapro (Abiraterone Acetate Tablets). The substance's active component, abiraterone acetate, prevents the generation of androgen, which is crucial for the development of prostate cancer. With or without prednisone, abirapro is specifically used in metastatic castration-resistant prostate cancer. The pills are swallowed, typically once daily. Fatigue, joint pain, hypertension, and fluid retention are typical adverse effects. During treatment, regular medical monitoring is crucial. In patients with advanced prostate cancer, abirapor has been found to increase survival and enhance quality of life, providing a potent therapy alternative for this difficult condition.

Abirapro's (Abiraterone Acetate Tablets) features and advantages include:

Features:

1. Abirapro contains abiraterone acetate, which blocks the creation of androgens like testosterone, which are necessary for the development of prostate cancer cells.

2. Treatment for metastatic castration-resistant prostate cancer: It is specifically suggested for the management of mCRPC.

3. Abirapro pills are administered orally, making it straightforward and simple to give.

4. Combination therapy: To increase the effectiveness of the medication, abiraterone acetate is frequently used with prednisone or prednisolone.

5. Dose once daily: The tablets are normally taken once daily, making it easier for patients to follow a dose schedule.

Benefits:

1. Extended survival: In patients with mCRPC, abirapro has shown promise in extending both overall survival and progression-free survival.

2. Increased quality of life: Abiraterone's ability to effectively treat cancer and manage its symptoms can result in an increase in quality of life.

3. Suppression of tumour growth: Abiraterone Acetate prevents androgen production, which reduces the development of prostate cancer tumours.

4. Delay in disease progression: Abirapro therapy for some mCRPC patients has been shown to provide disease control and increase life expectancy.

5. Abirapro provides palliative treatment, which reduces discomfort and enhances general wellbeing in men with advanced prostate cancer.

6. Non-invasive treatment: Because abiraterone acetate is administered orally, it offers patients a non-invasive treatment alternative.

7. Fewer hospital visits: Compared to intravenous treatments, oral delivery is more convenient and necessitates fewer hospital visits.

While Abirapro offers major advantages in the treatment of metastatic castration-resistant prostate cancer, it is crucial to emphasise that there may potentially be dangers and adverse effects. Healthcare workers should keep a tight eye on patients while they are receiving therapy, and any alarming symptoms should be immediately reported for proper management. In consultation with oncologists or other medical professionals skilled in treating prostate cancer, treatment choices should be made.

Abirapro (tablets containing abiraterone acetate) uses:

1. Abirapro is used to treat metastatic castration-resistant prostate cancer (mCRPC), a stage of the disease in which the cancer spreads despite hormonal treatments.

Abirapro (Abiraterone Acetate Tablets) side effects include:

1. Patients may feel weary or weak due to fatigue.

2. Joint discomfort: Abiraterone Acetate may result in joint soreness.

3. Hypertension: It could cause high blood pressure.

4. Some people may develop fluid retention, which can cause swelling in the legs or other body areas.

5. Abirapro may produce hot flashes, which are sudden feelings of warmth, typically felt in the face, neck, or chest.

6. Effects on the digestive system: It may produce diarrhoea, constipation, diarrhoea, or nausea.

7. Abnormalities in liver function tests could be caused by abiraterone acetate.

8. Rarely, it might result in adrenal insufficiency, which can produce symptoms including weariness and low blood pressure.

9. Cardiac conditions: In some instances, it has been linked to heart-related difficulties, such as heart failure.

10. Abiraterone may result in hypokalemia, or low potassium levels in the blood

11. Increased risk of fractures: In some patients, it may increase the risk of bone fractures.

12. Blood sugar elevation: Abirapro may result in blood sugar elevation.

13. Hepatotoxicity: In extremely rare cases, it may result in liver issues and elevated liver enzyme levels.

During Abirapro therapy, patients should be closely observed by medical personnel. Any symptoms that warrant further investigation should be reported right away to the healthcare professional as the medication carries a potential for serious adverse effects. In consultation with oncologists or other medical professionals skilled in treating prostate cancer, treatment choices should be made.

Abirapro Abiraterone Acetate Tablets Technical Details:

• Manufacturer : Glenmark
• Brand Name : Abirapro 
• Ingredient : Abiraterone Acetate
• Form : Tablet
• Power : 250mg
• Quantity : 120 tabs per bottle
• Use : Oral
• Packaging : Bottle